General Information of the Compound
| Compound ID |
CP0050763
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine
1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine
4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine
4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidene
4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine
4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine
5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene
Ciproheptadina
Ciproheptadina [INN-Spanish]
Ciprovit
Ciprovit (TN)
Cypoheptadine
Cyproheptadiene
Cyproheptadine
Cyproheptadine (INN)
Cyproheptadine Hcl
Cyproheptadine [INN:BAN]
Cyproheptadinum
Cyproheptadinum [INN-Latin]
Dibenzosuberonone/Cyproheptadine
Dihexazin
Dronactin
Eiproheptadine
MK 141
Periactin
Periactin (TN)
Periactine
Periactinol
Viternum
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H21N
|
||||||||||||||||||
| Molecular Weight |
287.406
|
||||||||||||||||||
| Canonical SMILES |
CN1CCC(CC1)=C1c2ccccc2C=Cc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
JJCFRYNCJDLXIK-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
129-03-3
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT05193, 5-hydroxytryptamine receptor 2C
Protein ID: PT00867, D(2) dopamine receptor
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Protein ID: PT01607, Sodium-dependent noradrenaline transporter
Protein ID: PT01609, Sodium-dependent serotonin transporter
Clinical Information about the Compound